Influence of food and diabetes on pharmacokinetics of sodium tungstate in rat

International Journal of Pharmaceutics

Volumn 248, Issue 1-2, 2002, Pages 131-139

  Le Lamer Dechamps S ^a   Poucheret, P ^a   Cros, G ^a   Bressolle, F ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Food; Healthy rats; Population approach; Sodium tungstate; Streptozotocin induced diabetic rats

Indexed keywords

STREPTOZOCIN; TUNGSTATE SODIUM; TUNGSTEN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; FLUID INTAKE; FOOD; FOOD INTAKE; MALE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RAT; STOMACH PARESIS;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DIABETES MELLITUS, EXPERIMENTAL; EATING; FOOD-DRUG INTERACTIONS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TUNGSTEN COMPOUNDS;

EID: 0037032438     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00424-6     Document Type: Article

References (27)

1. 181W labeled sodium tungstate by beagles. Health Phys. 24:1973;519-524.
2. Aarons L. Sparse data analysis. Eur. J. Drug Metab. Pharmacokinet. 1:1993;97-100.
3. Barbera A., Rodriguez-Gil J.E., Guinovart J.J. Insulin-like actions of Tungstate in Diabetic rats. Normalization of hepatic glucose metabolism. J. Biol. Chem. 269:1994;20047-20053.
4. Barbera A., Fernandez-Alvarez J., Truc A., Gomis R., Guinovart J.J. Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia. Diabetologia. 40:1997;143-149.
5. Barbera A., Gomis R.R., Prats N., Rodríguez-Gil J.E., Domingo M., Gomis R., Guinovart J.J. Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study. Diabetologia. 44:2001;507-513.
6. Bell M.C., Sneed N.N. Metabolism of tungsten by sheep and swine. Mills C.F., Trace Element Metabolism in Animals. 1970;70-72 Livingstone E and S, Edinburgh.
7. Bohlen H.G., Nase G.P., Jin J.S. Multiple mechanisms of early hyperglycaemic injury of the rat intestinal microcirculation. Clin. Exp. Pharmacol. Physiol. 29:2002;138-142.
8. Bouzom F., Laveille C., Merdjan H., Jochemsen R. Use of nonlinear mixed effect modeling for the meta-analysis of preclinical pharmacokinetic data: application to S 20342 in the rat. J. Pharm. Sci. 89:2000;603-613.
9. Burtin P., Mentré F., Van Bree J., Steimer J.L. Sparse sampling for assessment of drug exposure in toxicological studies. Eur. J. Metab. Pharmacokinet. 21:1996;105-111.
10. Cardin C.J., Mason J. Molybdate and tungstate transfer by rat ileum competitive inhibition by sulphate. Biochim. Biophys. Acta. 455:1976;937-946.
11. Chang F.Y., Doong M.L., Chen T.S., Lee S.D., Wang P.S. Altered intestinal transit is independent of gastroparesis in the early diabetic rats. Chin. J. Physiol. 40:1997;31-35.
12. Dempster A.P., Laird N.M., Rubin D.B. Maximum likelihood from incomplete data via the EM algorithm. J. Royal Stat. Soc. 39:1977;1-38.
13. Draper N., Smith H. Applied Regression Analysis. 1966;171-195 Wiley, New York. Chapter 6.
14. Gomeni R., Pineau G., Mentré F. Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package. Anticancer Res. 14:1994;2321-2326.
15. Kaye S.V. Distribution and retention of orally administered radiotungsten in the rat. Health Phys. 15:1968;399-417.
16. Leggett R.W. A model of the distribution and retention of tungsten in the human body. Sci. Total Environ. 206:1997;147-165.
17. Le Lamer S., Poucheret P., Cros G., Kiesgen de Richter R., Bonnet P.A., Bressolle F. Pharmacokinetics of sodium tungstate in rat and dog: a population approach. J. Pharmacol. Exp. Ther. 294:2000;74-80.
18. Le Lamer S., Cros G., Serrano J.J., Piñol C., Fernández-Alvarez J., Bressolle F. Estimation of pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in beagle dog. Eur. J. Pharm. Sci. 14:2001;323-329.
19. Le Lamer S., Cros G., Piñol C., Fernández-Alvarez J., Bressolle F. An application of population kinetics analysis to estimate pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in rats. Pharmacol. Toxicol. 90:2002;100-105.
20. Li J., Elberg G., Gefel D., Shechter Y. Permolybdate and pertungstate-potent stimulators of insulin effects in rat adipocytes: mechanism of action. Biochemistry. 34:1995;6218-6225.
21. 185W] thiotungstates injected into sheep and the influence of copper: their fate and the effect of the compounds upon plasma copper. J. Inorg. Biochem. 35:1989;115-126.
22. Mullen A.L., Bretthauer E.W., Stanley R.E. Absorption, distribution and milk secretion of radionuclides by the dairy cow. V. Radiotungsten Health Phys. 31:1976;417-424.
23. Poucheret P., Le Lamer S., Cros G., Kiesgen de Richter R., Bonnet P.A., Bressolle F. Tungsten determination in rat and dog plasma samples by inductively coupled plasma emission spectrometry. Application to preclinical pharmacokinetic studies. Anal. Chim. Acta. 405:2000;221-226.
24. P-PHARM user's guide, 1993, version 1.4, SIMED, Créteil, France.
25. Rodríguez-Gallardo J., Silvestre A.R., Egodo E.M., Marco J. Effects of sodium tungstate on insulin and glucagons secretion in the perfused rat pancreas. Eur. J. Pharmacol. 402:2000;199-204.
26. Sokal R.R., Rohlf J.R.N. Biometry. 1969;Freeman, San Francisco.
27. Young B.W., Bremner I., Mills C.F. Effects of tetrathiotungstate and dithiotungstate on copper metabolism in rats. J. Inorg. Biochem. 16:1982;121-134.